As previously reported, TD Securities resumed coverage of Docebo (DCBO) with a Buy rating and a price target of $37, down from $63. The firm likes Docebo’s product leadership driving expanding success with enterprise customers and sees a maturing U.S. Federal and enterprise pipeline as key drivers of revenue growth, as well as margin and multiple expansion, the analyst tells investors.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DCBO:
- Docebo resumed with a Buy at TD Securities
- Docebo’s Earnings Call Highlights Strategic Growth and Challenges
- Docebo price target raised to $46 from $43 at Canaccord
- Docebo Reports Strong Q2 2025 Financial Results
- Optimistic Buy Rating for Docebo Amid Strong Performance and Innovative Growth Prospects